卡培他滨联合洛铂治疗转移性乳腺癌的疗效和安全性(2)
[3]Moulder S， Hortobagyi GN.Advances in the treatment of breast cancer [J].Clin pharmacol Ther，2008，83(1)：26-36.
[4]Mariade F，Gilberto Amorim，Roberto Arecuri，et al.A Phase Ⅱ Study of Second-Line Neoadjuvant Chemotherapy With Capecitabine and Radiation Therapy for Anthracycline-Resistant Locally Advanced Breast Cancer[J].Americal Jourmal of Clinical Oncology，2007，30(1)：78-81.
[5]Hou G，Zhang S，zhang X，et al.Clinical pathological characteristics and prognostic analysis of 1013 breast cancer patients with diabetes. Breast Cancer Restreat，2013，137(3)：807-816.
[6]Daniele G，Gallo M，Piccirillo MC，et al. Pharmacokinetic evaluation of capecitabine in breast cancer [J] .Expert Opin Drug Metab Toxicol，2013，9(2)：225-235.
[7]Bonotto M， Bozza C，Di Loreto C，et al. Making capecitabine targeted therapy for breast cancer：which is the role of thymidine phosphorylase [J].Clin Breast Cancer，2013，13(3)：167-172.
[8]Stockler M R， Harvey Vj，Francis Pa，et al.Capecitabine versus classical cyclophospham ide， methotrexate，and fluorouracil as first line chem otherapy for advanced Breast cancer [J].J Clin Oncol，2011，29：4498-4504.
[9]刘德林，孙蔚莉，武渊，等.含洛铂的联合方案治疗晚期乳腺癌的临床观察[J].临床肿瘤杂志学，2013.18(2)：131.
[10]杨柳青，秦叔逸.第3代铂类药物洛铂的研究进展[J].临床肿瘤杂志学，2009，14(12)：1134-1139.编辑/蔡睿琳, 百拇医药(马玥诗 冀学宁 全秀莲)
[4]Mariade F，Gilberto Amorim，Roberto Arecuri，et al.A Phase Ⅱ Study of Second-Line Neoadjuvant Chemotherapy With Capecitabine and Radiation Therapy for Anthracycline-Resistant Locally Advanced Breast Cancer[J].Americal Jourmal of Clinical Oncology，2007，30(1)：78-81.
[5]Hou G，Zhang S，zhang X，et al.Clinical pathological characteristics and prognostic analysis of 1013 breast cancer patients with diabetes. Breast Cancer Restreat，2013，137(3)：807-816.
[6]Daniele G，Gallo M，Piccirillo MC，et al. Pharmacokinetic evaluation of capecitabine in breast cancer [J] .Expert Opin Drug Metab Toxicol，2013，9(2)：225-235.
[7]Bonotto M， Bozza C，Di Loreto C，et al. Making capecitabine targeted therapy for breast cancer：which is the role of thymidine phosphorylase [J].Clin Breast Cancer，2013，13(3)：167-172.
[8]Stockler M R， Harvey Vj，Francis Pa，et al.Capecitabine versus classical cyclophospham ide， methotrexate，and fluorouracil as first line chem otherapy for advanced Breast cancer [J].J Clin Oncol，2011，29：4498-4504.
[9]刘德林，孙蔚莉，武渊，等.含洛铂的联合方案治疗晚期乳腺癌的临床观察[J].临床肿瘤杂志学，2013.18(2)：131.
[10]杨柳青，秦叔逸.第3代铂类药物洛铂的研究进展[J].临床肿瘤杂志学，2009，14(12)：1134-1139.编辑/蔡睿琳, 百拇医药(马玥诗 冀学宁 全秀莲)